The neuroscience of placebo effects: Connecting context, learning and health

Nature Reviews Neuroscience

Volumn 16, Issue 7, 2015, Pages 403-418

  Wager, Tor D ^a   Atlas, Lauren Y ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ANALGESIA; AUTONOMIC NERVOUS SYSTEM FUNCTION; BRAIN FUNCTION; CONCEPTUAL FRAMEWORK; CONNECTING CONTEXT; DECISION MAKING; HEALTH; HUMAN; IMMUNE RESPONSE; LEARNING; MEDICAL RESEARCH; NEUROENDOCRINE SYSTEM; NEUROIMAGING; NEUROPSYCHOLOGY; NEUROSCIENCE; PAIN; PLACEBO EFFECT; PRIORITY JOURNAL; REVIEW; BRAIN; MENTAL FUNCTION; METABOLISM; NERVE TRACT; PHYSIOLOGY; PROCEDURES;

BRAIN; HUMANS; LEARNING; MENTAL PROCESSES; NEURAL PATHWAYS; NEUROSCIENCES; PAIN MANAGEMENT; PLACEBO EFFECT;

EID: 84932189077     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn3976     Document Type: Review

References (215)

1. Committee on Advancing Pain Research, Care, and Education in Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research (ed. Institute of Medicine of the National Academies) 1-350 (The National Academies Press, 2011).
2. Benedetti, F. Placebo effects: from the neurobiological paradigm to translational implications. Neuron 84, 623-637 (2014).
3. Walsh, B. T., Seidman, S. N., Sysko, R. & Gould, M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287, 1840-1847 (2002).
4. Benedetti, F., Carlino, E. & Pollo, A. How placebos change the patient's brain. Neuropsychopharmacology 36, 339-354 (2011).
5. Meissner, K. The placebo effect and the autonomic nervous system: evidence for an intimate relationship. Phil. Trans. R. Soc. B 366, 1808-1817 (2011).
6. Pressman, A., Avins, A. L., Neuhaus, J., Ackerson, L. & Rudd, P. Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST). Contemp. Clin. Trials 33, 492-498 (2012).
7. Schenk, L. A., Sprenger, C., Geuter, S. & Buchel, C. Expectation requires treatment to boost pain relief: an fMRI study. Pain 155, 150-157 (2014).
8. Colloca, L., Lopiano, L., Lanotte, M. & Benedetti, F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 3, 679-684 (2004).
9. Rohsenow, D. J. & Marlatt, G. A. The balanced placebo design: methodological considerations. Addict. Behav. 6, 107-122 (1981).
10. Kirsch, I. et al. Initial severity and antidepressant benefits: a meta-Analysis of data submitted to the Food and Drug Administration. PLoS Med. 5, e45 (2008).
11. Flood, A., Lorence, D., Ding, J., McPherson, K. & Black, N. A. The role of expectations in patients' reports of post-operative outcomes and improvement following therapy. Med. Care 31, 1043-1056 (1993).
12. Goetz, C. G. et al. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov. Disord. 23, 690-699 (2008).
13. Wampold, B. E. et al. A meta-Analysis of outcome studies comparing bona fide psychotherapies: empiricially, 'all must have prizes;. Psychol. Bull. 122, 203-215 (1997).
14. Kleijnen, J., de Craen, A. J., van Everdingen, J. & Krol, L. Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet 344, 1347-1349 (1994).
15. Flaten, M. A., Simonsen, T. & Olsen, H. Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosomat. Med. 61, 250-255 (1999).
16. Kong, J. et al. Expectancy and treatment interactions: a dissociation between acupuncture analgesia and expectancy evoked placebo analgesia. Neuroimage 45, 940-949 (2009).
17. Atlas, L. Y. et al. Dissociable influences of opiates and expectations on pain. J. Neurosci. 32, 8053-8064 (2012).
18. Atlas, L. Y., Wielgosz, J., Whittington, R. A. & Wager, T. D. Specifying the non-specific factors underlying opioid analgesia: expectancy, attention, and affect. Psychopharmacology 231, 813-823 (2014).
19. Benedetti, F. et al. The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression. Pain 75, 313-319 (1998).
20. Maren, S., Phan, K. L. & Liberzon, I. The contextual brain: implications for fear conditioning, extinction and psychopathology. Nat. Rev. Neurosci. 14, 417-428 (2013).
21. Buchel, C., Geuter, S., Sprenger, C. & Eippert, F. Placebo analgesia: a predictive coding perspective. Neuron 81, 1223-1239 (2014).
22. Sterzer, P., Frith, C. & Petrovic, P. Believing is seeing: expectations alter visual awareness. Curr. Biol. 18, R697-R698 (2008).
23. Summerfield, C. & de Lange, F. P. Expectation in perceptual decision making: neural and computational mechanisms. Nat. Rev. Neurosci. 15, 745-756 (2014).
24. Summerfield, C. & Egner, T. Expectation (and attention) in visual cognition. Trends Cogn. Sci. 13, 403-409 (2009).
25. Edelson, M., Sharot, T., Dolan, R. J. & Dudai, Y. Following the crowd: brain substrates of long-Term memory conformity. Science 333, 108-111 (2011).
26. Plassmann, H., O'Doherty, J., Shiv, B. & Rangel, A. Marketing actions can modulate neural representations of experienced pleasantness. Proc. Natl Acad. Sci. USA 105, 1050-1054 (2008).
27. Hare, T. A., Malmaud, J. & Rangel, A. Focusing attention on the health aspects of foods changes value signals in vmPFC and improves dietary choice. J. Neurosci. 31, 11077-11087 (2011).
28. Plassmann, H. & Wager, T. D. in The Interdisciplinary Science of Consumption (eds Kringelbach, M., Knutson, B. & Preston, S.) 219-240 (2014).
29. Beedie, C. J. & Foad, A. J. The placebo effect in sports performance. Sports Med. 39, 313-329 (2009).
30. Boot, W. R., Simons, D. J., Stothart, C. & Stutts, C. The pervasive problem with placebos in psychology why active control groups are not sufficient to rule out placebo effects. Persp. Psychol. Sci. 8, 445-454 (2013).
31. Carlino, E., Frisaldi, E. & Benedetti, F. Pain and the context. Nat. Rev. Rheumatol. 10, 348-355 (2014).
32. Sherman, R. & Hickner, J. Academic physicians use placebos in clinical practice and believe in the mind-body connection. J. Gen. Intern. Med. 23, 7-10 (2008).
33. Ochoa, J. L. Chronic pains associated with positive and negative sensory, motor, and vaso-motor manifestations: CPSMV (RSD; CRPS?). Heterogeneous somatic versus psychopathologic origins. Contemp. Neurol. 2, 1-20 (1997).
34. Barrett, B. et al. Placebo, meaning, and health. Perspect. Biol. Med. 49, 178-198 (2006).
35. Enck, P., Benedetti, F. & Schedlowski, M. New insights into the placebo and nocebo responses. Neuron 59, 195-206 (2008).
36. Vase, L., Petersen, G. L., Riley, J. L. & Price, D. D. Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain 145, 36-44 (2009).
37. Vase, L., Riley, J. L. & Price, D. D. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99, 443-452 (2002).
38. Kaptchuk, T. J. et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 336, 999-1003 (2008).
39. Kaptchuk, T. J. et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS ONE 5, e15591 (2010).
40. Kam-Hansen, S. et al. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci. Transl Med. 6, 218ra5 (2014).
41. Rutherford, B. R., Roose, S. P. & Sneed, J. Mind over medicine: the influence of expectations on antidepressant response. J. Am. Psychoanal. Assoc. 57, 456-460 (2009).
42. Kirsch, I. Listening to Prozac but hearing placebo: a meta-Analysis of antidepressant medication. Prevent. Treat. 1, Article 2A (1998).
43. Leuchter, A. F., Hunter, A. M., Tartter, M. & Cook, I. A. Role of pill-Taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. Br. J. Psychiatry 205, 443-449 (2014).
44. Lidstone, S. C. et al. Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch. Gen. Psychiatry 67, 857-865 (2010).
45. de la Fuente-Fernandez, R. et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293, 1164-1166 (2001).
46. Kemeny, M. E. et al. Placebo response in asthma: a robust and objective phenomenon. J. Allergy Clin. Immunol. 119, 1375-1381 (2007).
47. Luparello, T., Lyons, H. A., Bleecker, E. R. & McFadden, E. R. Jr. Influences of suggestion on airway reactivity in asthmatic subjects. Psychosomat. Med. 30, 819-825 (1968).
48. Wechsler, M. E. et al. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N. Engl. J. Med. 365, 119-126 (2011).
49. Vase, L., Robinson, M., Verne, G. & Price, D. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 105, 17-25 (2003).
50. Avins, A. L. et al. Placebo adherence and its association with morbidity and mortality in the studies of left ventricular dysfunction. J. Gen. Intern. Med. 25, 1275-1281 (2010).
51. Pollo, A., Vighetti, S., Rainero, I. & Benedetti, F. Placebo analgesia and the heart. Pain 102, 125-133 (2003).
52. Benedetti, F., Arduino, C. & Amanzio, M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J. Neurosci. 19, 3639-3648 (1999).
53. Bingel, U. et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci. Transl Med. 3, 70ra14 (2011).
54. Saper, C. B. The central autonomic nervous system: conscious visceral perception and autonomic pattern generation. Annu. Rev. Neurosci. 25, 433-469 (2002).
55. Price, J. Prefrontal cortical networks related to visceral function and mood. Ann. NY Acad. Sci. 877, 383-396 (1999).
56. Wager, T. D. et al. Brain mediators of cardiovascular responses to social threat, part II: prefrontal-subcortical pathways and relationship with anxiety. Neuroimage 47, 836-851 (2009).
57. Phelps, E. A. et al. Activation of the left amygdala to a cognitive representation of fear. Nat. Neurosci. 4, 437-441 (2001).
58. Grings, W. W., Schell, A. M. & Carey, C. A. Verbal control of an autonomic response in a cue reversal situation. J. Exp. Psychol. 99, 215-221 (1973).
59. Geuter, S. & Büchel, C. Facilitation of pain in the human spinal cord by nocebo treatment. J. Neurosci. 33, 13784-13790 (2013).
60. Nakamura, Y. et al. Investigating dose-dependent effects of placebo analgesia: a psychophysiological approach. Pain 153, 227-237 (2012).
61. Eippert, F. et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63, 533-543 (2009).
62. Benedetti, F., Amanzio, M., Vighetti, S. & Asteggiano, G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J. Neurosci. 26, 12014-12022 (2006).
63. Johansen, O., Brox, J. & Flaten, M. A. Placebo and nocebo responses, cortisol, and circulating β-endorphin. Psychosomat. Med. 65, 786-790 (2003).
64. Guo, J. Y. et al. Placebo analgesia affects the behavioral despair tests and hormonal secretions in mice. Psychopharmacology 217, 83-90 (2011).
65. Benedetti, F. et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J. Neurosci. 23, 4315-4323 (2003).
66. Crum, A. J., Corbin, W. R., Brownell, K. D. & Salovey, P. Mind over milkshakes: mindsets, not just nutrients, determine ghrelin response. Health Psychol. 30, 424-429 (2011).
67. Woods, S. C. & Ramsay, D. S. Pavlovian influences over food and drug intake. Behav. Brain Res. 110, 175-182 (2000).
68. Ader, R. & Cohen, N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 215, 1534-1536 (1982).
69. Goebel, M. U. et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB J. 16, 1869-1873 (2002).
70. Schedlowski, M. & Pacheco-Lopez, G. The learned immune response: Pavlov and beyond. Brain Behav. Immun. 24, 176-185 (2010).
71. Exton, M. S. et al. Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and β-Adrenoceptors. J. Neuroimmunol. 131, 21-30 (2002).
72. Pacheco-Lopez, G. et al. Neural substrates for behaviorally conditioned immunosuppression in the rat. J. Neurosci. 25, 2330-2337 (2005).
73. Ober, K. et al. Plasma noradrenaline and state anxiety levels predict placebo response in learned immunosuppression. Clin. Pharmacol. Ther. 91, 220-226 (2012).
74. Kamenica, E., Naclerio, R. & Malani, A. Advertisements impact the physiological efficacy of a branded drug. Proc. Natl Acad. Sci. USA 110, 12931-12935 (2013).
75. Tversky, A. & Kahneman, D. Judgment under uncertainty: heuristics and biases. Science 185, 1124-1131 (1974).
76. Staudinger, M. R. & Buchel, C. How initial confirmatory experience potentiates the detrimental influence of bad advice. Neuroimage 76, 125-133 (2013).
77. Wager, T. D., Matre, D. & Casey, K. L. Placebo effects in laser-evoked pain potentials. Brain Behav. Immun. 20, 219-230 (2006).
78. Martini, M., Lee, M., Valentini, E. & Iannetti, G. Intracortical modulation, and not spinal inhibition, mediates placebo analgesia. Eur. J. Neurosci. 41, 498-504 (2015).
79. Halperin, E., Russell, A. G., Trzesniewski, K. H., Gross, J. J. & Dweck, C. S. Promoting the Middle East peace process by changing beliefs about group malleability. Science 333, 1767-1769 (2011).
80. Petrovic, P. et al. Placebo in emotional processing-induced expectations of anxiety relief activate a generalized modulatory network. Neuron 46, 957-969 (2005).
81. Zhang, W., Guo, J., Zhang, J. & Luo, J. Neural mechanism of placebo effects and cognitive reappraisal in emotion regulation. Prog. Neuropsychopharmacol. Biol. Psychiatry 40, 364-373 (2013).
82. Zhang, W. & Luo, J. The transferable placebo effect from pain to emotion: changes in behavior and EEG activity. Psychophysiology 46, 626-634 (2009).
83. Schienle, A., Übel, S., Schöngabner, F., Ille, R. & Scharmüller, W. Disgust regulation via placebo: an fMRI study. Soc. Cogn. Affect. Neurosci. 9, 985-990 (2013).
84. Schienle, A., Übel, S. & Scharmüller, W. Placebo treatment can alter primary visual cortex activity and connectivity. Neuroscience 263, 125-129 (2014).
85. Schmidt, L., Braun, E. K., Wager, T. D. & Shohamy, D. Mind matters: placebo enhances reward learning in Parkinson's disease. Nat. Neurosci. 17, 1793-1797 (2014).
86. Mayberg, H. S. et al. The functional neuroanatomy of the placebo effect. Am. J. Psychiatry 159, 728-737 (2002).
87. Leuchter, A. F., Cook, I. A., Witte, E. A., Morgan, M. & Abrams, M. Changes in brain function of depressed subjects during treatment with placebo. Am. J. Psychiatry 159, 122-129 (2002).
88. Apkarian, A. V., Bushnell, M. C., Treede, R. D. & Zubieta, J. K. Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain 9, 463-484 (2005).
89. Watson, A. et al. Placebo conditioning and placebo analgesia modulate a common brain network during pain anticipation and perception. Pain 145, 24-30 (2009).
90. Wager, T. D. et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 303, 1162-1167 (2004).
91. Price, D. D., Craggs, J., Verne, G. N., Perlstein, W. M. & Robinson, M. E. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 127, 63-72 (2007).
92. Koyama, T., McHaffie, J. G., Laurienti, P. & Coghill, R. C. The subjective experience of pain: where expectations become reality. Proc. Natl Acad. Sci. USA 102, 12950-12955 (2005).
93. Keltner, J. et al. Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J. Neurosci. 26, 4437-4443 (2006).
94. Geuter, S., Eippert, F., Attar, C. H. & Büchel, C. Cortical and subcortical responses to high and low effective placebo treatments. Neuroimage 67, 227-236 (2013).
95. Wiech, K. et al. Anterior insula integrates information about salience into perceptual decisions about pain. J. Neurosci. 30, 16324-16331 (2010).
96. Lee, H. F. et al. Enhanced affect/cognition-related brain responses during visceral placebo analgesia in irritable bowel syndrome patients. Pain 153, 1301-1310 (2012).
97. Lu, H.-C. et al. Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: a 3T-fMRI study. Pain 148, 75-83 (2009).
98. Atlas, L. Y., Bolger, N., Lindquist, M. A. & Wager, T. D. Brain mediators of predictive cue effects on perceived pain. J. Neurosci. 30, 12964-12977 (2010).
99. Kong, J. et al. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J. Neurosci. 26, 381-388 (2006).
100. Wager, T. D., Atlas, L. Y., Leotti, L. A. & Rilling, J. K. Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. J. Neurosci. 31, 439-452 (2011).
101. Elsenbruch, S. et al. Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders. Pain 153, 382-390 (2012).
102. Kong, J. et al. Functional connectivity of the frontoparietal network predicts cognitive modulation of pain. Pain 154, 459-467 (2013).
103. Atlas, L. Y. & Wager, T. D. in Placebo (eds Benedetti, F., Enck, P., Frisaldi, E. & Schedlowski, M.) 37-69 (Springer, 2014).
104. Koban, L., Ruzic, L. & Wager, T. D. in Placebo and Pain (eds Colloca, L., Flaten, M. A. & Meissner, K.) 89-102 (Academic, 2013).
105. Amanzio, M., Benedetti, F., Porro, C. A., Palermo, S. & Cauda, F. Activation likelihood estimation meta-Analysis of brain correlates of placebo analgesia in human experimental pain. Hum. Brain Mapp. 34, 738-752 (2013).
106. Woo, C.-W., Roy, M., Buhle, J. T. & Wager, T. Distinct brain systems mediate the effects of nociceptive input and self-regulation on pain. PLoS Biol. 13, e1002036 (2015).
107. Lorenz, J. et al. Cortical correlates of false expectations during pain intensity judgments-A possible manifestation of placebo/nocebo cognitions. Brain Behav. Immun. 19, 283-295 (2005).
108. Aslaksen, P. M., Bystad, M., Vambheim, S. M. & Flaten, M. A. Gender differences in placebo analgesia: event-related potentials and emotional modulation. Psychosomat. Med. 73, 193-199 (2011).
109. Colloca, L. et al. Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain 139, 306-314 (2009).
110. Watson, A., El-Deredy, W., Vogt, B. A. & Jones, A. K. Placebo analgesia is not due to compliance or habituation: EEG and behavioural evidence. Neuroreport 18, 771-775 (2007).
111. Yarkoni, T., Poldrack, R. A., Nichols, T. E., Van Essen, D. C. & Wager, T. D. Large-scale automated synthesis of human functional neuroimaging data. Nat. Methods 8, 665-670 (2011).
112. Kross, E., Berman, M. G., Mischel, W., Smith, E. E. & Wager, T. D. Social rejection shares somatosensory representations with physical pain. Proc. Natl Acad. Sci. USA 108, 6270-6275 (2011).
113. Davis, K. D., Taylor, S. J., Crawley, A. P., Wood, M. L. & Mikulis, D. J. Functional MRI of pain-And attention-related activations in the human cingulate cortex. J. Neurophysiol. 77, 3370-3380 (1997).
114. Lindquist, K. A., Wager, T. D., Kober, H., Bliss-Moreau, E. & Barrett, L. F. The brain basis of emotion: a meta-Analytic review. Behav. Brain Sci. 35, 121-143 (2012).
115. Woo, C. W. et al. Separate neural representations for physical pain and social rejection. Nat. Commun. 5, 5380 (2014).
116. Craig, A. D., Chen, K., Bandy, D. & Reiman, E. M. Thermosensory activation of insular cortex. Nat. Neurosci. 3, 184-190 (2000).
117. Porreca, F., Ossipov, M. H. & Gebhart, G. Chronic pain and medullary descending facilitation. Trends Neurosci. 25, 319-325 (2002).
118. Gebhart, G. Descending modulation of pain. Neurosci. Biobehav. Rev. 27, 729-737 (2004).
119. Heinricher, M. & Fields, H. in Wall & Melzack's Textbook of Pain (eds McMahon, S., Koltzenburg, M., Tracey, I. & Turk, D. C.) 129-142 (Elsevier Health Sciences, 2013).
120. Fields, H. L. State-dependent opioid control of pain. Nat. Rev. Neurosci. 5, 565-575 (2004).
121. Barbas, H., Saha, S., Rempel-Clower, N. & Ghashghaei, T. Serial pathways from primate prefrontal cortex to autonomic areas may influence emotional expression. BMC Neurosci. 4, 25 (2003).
122. Keay, K. & Bandler, R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci. Biobehav. Rev. 25, 669-678 (2001).
123. Wright, J. S. & Panksepp, J. Toward affective circuit-based preclinical models of depression: sensitizing dorsal PAG arousal leads to sustained suppression of positive affect in rats. Neurosci. Biobehav. Rev. 35, 1902-1915 (2011).
124. Satpute, A. B. et al. Identification of discrete functional subregions of the human periaqueductal gray. Proc. Natl Acad. Sci. USA 110, 17101-17106 (2013).
125. Linnman, C., Moulton, E. A., Barmettler, G., Becerra, L. & Borsook, D. Neuroimaging of the periaqueductal gray: state of the field. Neuroimage 60, 505-522 (2012).
126. Buhle, J. T. et al. Common representation of pain and negative emotion in the midbrain periaqueductal gray. Soc. Cogn. Affect. Neurosci. 8, 609-616 (2013).
127. Levine, J. D., Gordon, N. C. & Fields, H. L. The mechanism of placebo analgesia. Lancet 2, 654-657 (1978).
128. Benedetti, F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64, 535-543 (1996).
129. Wager, T. & Scott, D. Placebo effects on human μ-opioid activity during pain. Proc. Natl Acad. Sci. USA 104, 11056-11061 (2007).
130. Scott, D. J. et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatry 65, 220-231 (2008).
131. Zubieta, J. et al. Placebo effects mediated by endogenous opioid activity on μ-opioid receptors. J. Neurosci. 25, 7754-7762 (2005).
132. Pecia, M. et al. Personality trait predictors of placebo analgesia and neurobiological correlates. Neuropsychopharmacology 38, 639-646 (2013).
133. Eippert, F., Finsterbusch, J., Bingel, U. & Büchel, C. Direct evidence for spinal cord involvement in placebo analgesia. Science 326, 404 (2009).
134. Matre, D., Casey, K. L. & Knardahl, S. Placebo-induced changes in spinal cord pain processing. J. Neurosci. 26, 559-563 (2006).
135. Goffaux, P., de Souza, J., Potvin, S. & Marchand, S. Pain relief through expectation supersedes descending inhibitory deficits in fibromyalgia patients. Pain 145, 18-23 (2009).
136. Petrovic, P., Kalso, E., Petersson, K. M. & Ingvar, M. Placebo and opioid analgesia-imaging a shared neuronal network. Science 295, 1737-1740 (2002).
137. Craggs, J. G., Price, D. D., Perlstein, W. M., Verne, G. N. & Robinson, M. E. The dynamic mechanisms of placebo induced analgesia: evidence of sustained and transient regional involvement. Pain 139, 660-669 (2008).
138. Lui, F. et al. Neural bases of conditioned placebo analgesia. Pain 151, 816-824 (2010).
139. Bingel, U., Lorenz, J., Schoell, E., Weiller, C. & Buchel, C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120, 8-15 (2006).
140. Borckardt, J. J. et al. Postoperative left prefrontal repetitive transcranial magnetic stimulation reduces patient-controlled analgesia use. Anesthesiology 105, 557-562 (2006).
141. Krummenacher, P., Candia, V., Folkers, G., Schedlowski, M. & Schonbachler, G. Prefrontal cortex modulates placebo analgesia. Pain 148, 368-374 (2010).
142. Stein, N., Sprenger, C., Scholz, J., Wiech, K. & Bingel, U. White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain 153, 2210-2217 (2012).
143. Zhang, Y. Q., Tang, J. S., Yuan, B. & Jia, H. Inhibitory effects of electrically evoked activation of ventrolateral orbital cortex on the tail-flick reflex are mediated by periaqueductal gray in rats. Pain 72, 127-135 (1997).
144. Zhang, S., Tang, J. S., Yuan, B. & Jia, H. Electrically-evoked inhibitory effects of the nucleus submedius on the jaw-opening reflex are mediated by ventrolateral orbital cortex and periaqueductal gray matter in the rat. Neuroscience 92, 867-875 (1999).
145. Johansen, J. P. et al. Optical activation of lateral amygdala pyramidal cells instructs associative fear learning. Proc. Natl Acad. Sci. USA 107, 12692-12697 (2010).
146. Helmstetter, F. J., Tershner, S. A., Poore, L. H. & Bellgowan, P. S. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla. Brain Res. 779, 104-118 (1998).
147. Schultz, W., Dayan, P. & Montague, P. R. A neural substrate of prediction and reward. Science 275, 1593-1599 (1997).
148. Kober, H. et al. Prefrontal-striatal pathway underlies cognitive regulation of craving. Proc. Natl Acad. Sci. USA 107, 14811-14816 (2010).
149. Zaki, J., Schirmer, J. & Mitchell, J. P. Social influence modulates the neural computation of value. Psychol. Sci. 22, 894-900 (2011).
150. Demos, K. E., Heatherton, T. F. & Kelley, W. M. Individual differences in nucleus accumbens activity to food and sexual images predict weight gain and sexual behavior. J. Neurosci. 32, 5549-5552 (2012).
151. Berridge, K. C. & Robinson, T. E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Brain Res. Rev. 28, 309-369 (1998).
152. Wager, T. D., Hughes, B., Davidson, M., Lindquist, M. L. & Ochsner, K. N. Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron 59, 1037-1050 (2008).
153. Navratilova, E. & Porreca, F. Reward and motivation in pain and pain relief. Nat. Neurosci. 17, 1304-1312 (2014).
154. Schwartz, N. et al. Decreased motivation during chronic pain requires long-Term depression in the nucleus accumbens. Science 345, 535-542 (2014).
155. Metz, A. E., Yau, H.-J., Centeno, M. V., Apkarian, A. V. & Martina, M. Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain. Proc. Natl Acad. Sci. USA 106, 2423-2428 (2009).
156. Baliki, M. N. et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat. Neurosci. 15, 1117-1119 (2012).
157. Schweinhardt, P., Seminowicz, D. A., Jaeger, E., Duncan, G. H. & Bushnell, M. C. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J. Neurosci. 29, 4882-4887 (2009).
158. Scott, D. J. et al. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55, 325-336 (2007).
159. Wanigasekera, V. et al. Baseline reward circuitry activity and trait reward responsiveness predict expression of opioid analgesia in healthy subjects. Proc. Natl Acad. Sci. USA 109, 17705-17710 (2012).
160. Zhang, W., Qin, S., Guo, J. & Luo, J. A follow-up fMRI study of a transferable placebo anxiolytic effect. Psychophysiology 48, 1119-1128 (2011).
161. Benedetti, F. et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat. Neurosci. 7, 587-588 (2004).
162. Drevets, W. C. et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827 (1997).
163. Mayberg, H. S. et al. Deep brain stimulation for treatment-resistant depression. Neuron 45, 651-660 (2005).
164. Petrovic, P. et al. A prefrontal non-opioid mechanism in placebo analgesia. Pain 150, 59-65 (2010).
165. Ellingsen, D.-M. et al. Placebo improves pleasure and pain through opposite modulation of sensory processing. Proc. Natl Acad. Sci. USA 110, 17993-17998 (2013).
166. Kessner, S., Sprenger, C., Wrobel, N., Wiech, K. & Bingel, U. Effect of oxytocin on placebo analgesia: a randomized study. JAMA 310, 1733-1735 (2013).
167. Rahnev, D., Lau, H. & de Lange, F. P. Prior expectation modulates the interaction between sensory and prefrontal regions in the human brain. J. Neurosci. 31, 10741-10748 (2011).
168. Kok, P., Brouwer, G. J., van Gerven, M. A. & de Lange, F. P. Prior expectations bias sensory representations in visual cortex. J. Neurosci. 33, 16275-16284 (2013).
169. Flaten, M. A., Aslaksen, P. M., Lyby, P. S. & Bjorkedal, E. The relation of emotions to placebo responses. Phil. Trans. R. Soc. B 366, 1818-1827 (2011).
170. Roy, M., Shohamy, D. & Wager, T. D. Ventromedial prefrontal-subcortical systems and the generation of affective meaning. Trends Cogn. Sci. 16, 147-156 (2012).
171. Chib, V. S., Rangel, A., Shimojo, S. & O'Doherty, J. P. Evidence for a common representation of decision values for dissimilar goods in human ventromedial prefrontal cortex. J. Neurosci. 29, 12315-12320 (2009).
172. Hare, T. A., Camerer, C. F. & Rangel, A. Self-control in decision-making involves modulation of the vmPFC valuation system. Science 324, 646-648 (2009).
173. Falk, E. B., Berkman, E. T., Whalen, D. & Lieberman, M. D. Neural activity during health messaging predicts reductions in smoking above and beyond self-report. Health Psychol. 30, 177-185 (2011).
174. Wager, T. et al. An fMRI-based neurologic signature of physical pain. N. Engl. J. Med. 368, 1388-1397 (2013).
175. Rescorla, R. A. Pavlovian conditioning. It's not what you think it is. Am. Psychol. 43, 151-160 (1988).
176. Gallistel, C. R. & Matzel, L. D. The neuroscience of learning: beyond the Hebbian synapse. Annu. Rev. Psychol. 64, 169-200 (2013).
177. Schoenbaum, G., Roesch, M. R., Stalnaker, T. A. & Takahashi, Y. K. A new perspective on the role of the orbitofrontal cortex in adaptive behaviour. Nat. Rev. Neurosci. 10, 885-892 (2009).
178. Kirsch, I., Lynn, S. J., Vigorito, M. & Miller, R. R. The role of cognition in classical and operant conditioning. J. Clin. Psychol. 60, 369-392 (2004).
179. Stewart-Williams, S. & Podd, J. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol. Bull. 130, 324-340 (2004).
180. Kirsch, I. Response expectancy as a determinant of experience and behavior. Am. Psychol. 40, 1189-1202 (1985).
181. Voudouris, N. J., Peck, C. L. & Coleman, G. Conditioned placebo responses. J. Pers. Soc. Psychol. 48, 47-53 (1985).
182. Wickramasekera, I. A conditioned response model of the placebo effect; predictions from the model. Biofeedback Self Regul. 5, 5-18 (1980).
183. Carlino, E. et al. Role of explicit verbal information in conditioned analgesia. Eur. J. Pain 19, 546-553 (2015).
184. Montgomery, G. H. & Kirsch, I. Classical conditioning and the placebo effect. Pain 72, 107-113 (1997).
185. Wendt, L. et al. Placebo-induced immunosuppression in humans: role of learning and expectation. Brain Behav. Immun. 29, S17 (2013).
186. Benedetti, F., Amanzio, M., Baldi, S., Casadio, C. & Maggi, G. Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur. J. Neurosci. 11, 625-631 (1999).
187. Morton, D. L., Watson, A., El-Deredy, W. & Jones, A. K. Reproducibility of placebo analgesia: effect of dispositional optimism. Pain 146, 194-198 (2009).
188. Morton, D. L., Brown, C. A., Watson, A., El-Deredy, W. & Jones, A. K. Cognitive changes as a result of a single exposure to placebo. Neuropsychologia 48, 1958-1964 (2010).
189. Doll, B. B., Jacobs, W. J., Sanfey, A. G. & Frank, M. J. Instructional control of reinforcement learning: a behavioral and neurocomputational investigation. Brain Res. 1299, 74-94 (2009).
190. Biele, G., Rieskamp, J., Krugel, L. K. & Heekeren, H. R. The neural basis of following advice. PLoS Biol. 9, e1001089 (2011).
191. Li, J., Delgado, M. R. & Phelps, E. A. How instructed knowledge modulates the neural systems of reward learning. Proc. Natl Acad. Sci. USA 108, 55-60 (2011).
192. Vase, L., Robinson, M., Verne, G. & Price, D. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 115, 338-347 (2005).
193. Kirsch, I. & Henry, D. Extinction versus credibility in the desensitization of speech anxiety. J. Consult. Clin. Psychol. 45, 1052-1059 (1977).
194. Cliffer, K. D., Burstein, R. & Giesler, G. J. Jr. Distributions of spinothalamic, spinohypothalamic, and spinotelencephalic fibers revealed by anterograde transport of PHA-L in rats. J. Neurosci. 11, 852-868 (1991).
195. Willis, W. D. & Westlund, K. N. Neuroanatomy of the pain system and of the pathways that modulate pain. J. Clin. Neurophysiol. 14, 2-31 (1997).
196. Bandler, R., Keay, K. A., Floyd, N. & Price, J. Central circuits mediating patterned autonomic activity during active versus passive emotional coping. Brain Res. Bull. 53, 95-104 (2000).
197. Watkins, L. R. & Mayer, D. J. Organization of endogenous opiate and nonopiate pain control systems. Science 216, 1185-1192 (1982).
198. Altier, N. & Stewart, J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 65, 2269-2287 (1999).
199. Gear, R. W., Aley, K. O. & Levine, J. D. Pain-induced analgesia mediated by mesolimbic reward circuits. J. Neurosci. 19, 7175-7181 (1999).
200. Helmstetter, F. J. Stress-induced hypoalgesia and defensive freezing are attenuated by application of diazepam to the amygdala. Pharmacol. Biochem. Behav. 44, 433-438 (1993).
201. Butler, R. K. & Finn, D. P. Stress-induced analgesia. Prog. Neurobiol. 88, 184-202 (2009).
202. Yang, J. et al. Central oxytocin enhances antinociception in the rat. Peptides 28, 1113-1119 (2007).
203. Lund, I. et al. Repeated massage-like stimulation induces long-Term effects on nociception: contribution of oxytocinergic mechanisms. Eur. J. Neurosci. 16, 330-338 (2002).
204. Yang, J. et al. Oxytocin in the periaqueductal gray participates in pain modulation in the rat by influencing endogenous opiate peptides. Peptides 32, 1255-1261 (2011).
205. Watkins, L. R., Kinscheck, I. B. & Mayer, D. J. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science 224, 395-396 (1984).
206. Wiertelak, E. P., Maier, S. F. & Watkins, L. R. Cholecystokinin antianalgesia: safety cues abolish morphine analgesia. Science 256, 830-833 (1992).
207. Dum, J. & Herz, A. Endorphinergic modulation of neural reward systems indicated by behavioral changes. Pharmacol. Biochem. Behav. 21, 259-266 (1984).
208. Rodgers, R. J. & Hendrie, C. A. Social conflict activates status-dependent endogenous analgesic or hyperalgesic mechanisms in male mice: effects of naloxone on nociception and behaviour. Physiol. Behav. 30, 775-780 (1983).
209. Langford, D. J. et al. Varying perceived social threat modulates pain behavior in male mice. J. Pain 12, 125-132 (2011).
210. Shyu, B. C., Sikes, R. W., Vogt, L. J. & Vogt, B. A. Nociceptive processing by anterior cingulate pyramidal neurons. J. Neurophysiol. 103, 3287-3301 (2010).
211. Logothetis, N. K. What we can do and what we cannot do with fMRI. Nature 453, 869-878 (2008).
212. Moerman, D. E. Meaning, Medicine and the 'Placebo Effect' (Cambridge Univ. Press, 2002).
213. Benedetti, F., Durando, J. & Vighetti, S. Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. Pain 155, 921-928 (2014).
214. Orne, T. M. On the social psychology of the psychological experiment: with particular reference to demand characteristics and their implications. Am. Psychol. 17, 776-783 (1962).
215. Xie, J. Y. et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J. Neurosci. 25, 409-416 (2005).